Journal
CLINICAL TRANSPLANTATION
Volume 35, Issue 3, Pages -Publisher
WILEY
DOI: 10.1111/ctr.14211
Keywords
ex vivo liver perfusion; graft survival; liver transplant; machine perfusion; retransplantation
Categories
Funding
- American Liver Foundation (2019 Hans Popper Memorial Postdoctoral Research Fellowship)
- American College of Surgeons [1123-39991]
- National Natural Science Foundation of China [81570679]
- Beijing NOVA program [Z161100004916141]
- National Institutes of Health [R01DK096075, R01DK107875]
Ask authors/readers for more resources
Increased clinical experience with DCD LT has led to higher utilization rates of livers from DCD donors, shorter ischemic and hospitalization times, and lower rates of retransplantation. Over the past decade, the rate of DCD LTs conducted in the United States has outpaced that of DBD, indicating an opportunity to capitalize on underutilized DCD liver allografts to mitigate the organ shortage in liver transplantation.
Compared to donation after brain death (DBD), livers procured for transplantation from donation after circulatory death (DCD) donors experience more ischemia-reperfusion injury and higher rates of ischemic cholangiopathy due to the period of warm ischemic time (WIT) following withdrawal of life support. As a result, utilization of DCD livers for liver transplant (LT) has generally been limited to short WITs and younger aged donor grafts, causing many recovered DCD organs to be discarded without consideration for transplant. This study assesses how DCD liver utilization and outcomes have changed over time, using OPTN data from adult, first-time, deceased donor, whole-organ LTs between January 1995 and December 2019. Results show that increased clinical experience with DCD LT has translated into increased use of livers from DCD donors, shorter ischemic times, shorter lengths of hospitalization after transplant, and lower rates of retransplantation. The data also reveal that over the past decade, the rate of increase in DCD LTs conducted in the United States has outpaced that of DBD. Together, these trends signal an opportunity for the field of liver transplantation to mitigate the organ shortage by capitalizing on DCD liver allografts that are currently not being utilized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available